Patient Gateway

RSS Feed

BeyondSpring Inc. Announces FDA Fast Track Designation For Plinabulin And Docetaxel In Post-ICI Non-Squamous NSCLC

AstraZeneca submits NDA for savolitinib + Tagrisso for NSCLC

CSCO 2026前沿速递 | 宗艾替尼立足HER2突变晚期NSCLC，开启多瘤种探索新方向_腾讯新闻

2026 CSCO 圆桌论道丨REPOWER研究：构建ROS1阳性NSCLC真实世界全程管理新范式_腾讯新闻

Impact of post-resistance molecular retesting strategies on treatment timeliness and clinical outcomes in EGFR-mutant advanced NSCLC: a real-world study

Neoadjuvant serplulimab combined with chemotherapy in locally advanced driver gene-negative squamous NSCLC: a multicenter observational study